Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063255 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL599148 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL30304219 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL6138427 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL597876 | 0.97 | ALDH1A1 (0.35) | ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL5388609 | 0.94 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10 | |
| SCHEMBL29350927 | 0.94 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10 | |
| Potassium SCHEMBL15329440 | 0.94 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL9515311 | 0.94 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL10440227 | 0.94 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2875813-B1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION | SBI PHARMACEUTICALS CO LTD (JP) | 2018-04-18 | — | — | EP | claimed |
| US-20170056351-A1 | COMPOSITION FOR INDUCING TUMOR IMMUNITY | UNIVERISTY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, JAPAN (JP) | 2017-03-02 | — | — | US | claimed |
| US-9351949-B2 | Prophylactic/therapeutic agent for influenza virus infection | SBI PHARMACEUTICALS CO., LTD. (JP) | 2016-05-31 | — | — | US | claimed |
| US-20150164838-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION | SBI PHARMACEUTICALS CO., LTD. (JP) | 2015-06-18 | — | — | US | claimed |
| EP-2875813-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION | SBI Pharmaceuticals Co., Ltd. (JP) | 2015-05-27 | — | — | EP | claimed |
| US-4707434-A | Color image forming method comprising processing with a bleach-fixing solution | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1987-11-17 | — | — | US | claimed |
| CN-104487066-B | Prophylactic and/or therapeutic agent for radiation damage | 国立大学法人东京大学 | 2020-06-09 | — | — | CN | disclosed |
| EP-3020476-B1 | OXYGEN REDUCTION CATALYST AND USE THEREFOR | SHOWA DENKO KK (JP) | 2019-09-11 | — | — | EP | disclosed |
| EP-2875813-B1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION | SBI PHARMACEUTICALS CO LTD (JP) | 2018-04-18 | — | — | EP | disclosed |
| US-9660272-B2 | Oxygen reduction catalyst and use thereof | SHOWA DENKO K.K. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20170056351-A1 | COMPOSITION FOR INDUCING TUMOR IMMUNITY | UNIVERISTY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, JAPAN (JP) | 2017-03-02 | — | — | US | disclosed |
| US-9351949-B2 | Prophylactic/therapeutic agent for influenza virus infection | SBI PHARMACEUTICALS CO., LTD. (JP) | 2016-05-31 | — | — | US | disclosed |
| US-20160149225-A1 | OXYGEN REDUCTION CATALYST AND USE THEREOF | SHOW DENKO K.K. (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-0244177-A2 | Method for processing light-sensitive silver halide color photographic material | KONICA CORPORATION (JP) | 1987-11-04 | — | — | EP | disclosed |
| US-4536472-A | IMPROVED GRANULARITY AND VISUAL SENSATION OF GRAININESS | FUJI PHOTO FILM CO., LTD. (JP) | 1985-08-20 | — | — | US | disclosed |
| EP-0114674-A2 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-08-01 | — | — | EP | disclosed |
| US-4327173-A | CYANINE DYE-FORMING COUPLER; HEAT RESISTANCE; PHOTOSTABILITY; COLORFASTNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1982-04-27 | — | — | US | disclosed |
| US-4221860-A | COLOR REVERSAL, DEVELOPMENT WITH COMPETING COUPLER, EMULSION CONTAINING BLUE-SENSITIVE METHYLENE COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1980-09-09 | — | — | US | disclosed |
| US-4120725-A | POLYMERS OF ACRYLIC AMIDES AND OF VINYL OR ALLYL ALCOHOLS, VINYL IMIDES OR AMIDES OR VINYL MORPHOLINE | FUJI PHOTO FILM CO., LTD. (JP) | 1978-10-17 | — | — | US | disclosed |
| US-4012258-A | POLY-FLUORO-ALKYL MAGENTA OR CYAN COUPLER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164838-A1 | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION | ALAD, AADAT, ATP5MG | ALDH1A1 534/4885TSHR 1978/4885LMNA 979/4885 |
| US-20170056351-A1 | COMPOSITION FOR INDUCING TUMOR IMMUNITY | IFNG, MYD88, IL2 | ALDH1A1 4588/4885TSHR 4465/4885LMNA 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.